Industry:
Drug Manufacturing,
Pharmaceuticals,
Biotechnology
ExonHit Therapeutics is the world's leader in the analysis of alternative RNA splicing, a process which when deregulated plays a key role in the onset of various diseases. ExonHit has a multi-component commercial strategy to capture the maximum value from its leadership in alternative splicing. The Company is already generating revenues from a new generation of microarrays, SpliceArrayTM family of products, which enable life science researchers to detect crucial disease-associated information. These products are marketed worldwide in conjunction with Agilent and
Contact with Exonhit Therapeutics SA:
Avenel Business Park 217 Perry Parkway
Gaithersburg,
Maryland
20877
USA
Tel: (240) 683-7070
Fax: (240) 683-7060
Web Site: www.exonhit.com
Instant Messenger:
N/A